← Evidence map

ArticleJournal of the American Society of Nephrology : JASN2015

Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model.

Katharina Hopp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

71 papers cite itlatest 60 shown

2015
…
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24994926